It is important we prioritise health research and development, including basic science, public health, behavioural science, and innovation development. The UK’s health sector has clear strengths. It has an enviable academic base, delivers strong return on investment, and is home to an exciting range of businesses with the potential to grow. As we build the role of science in our economy, health research and the life sciences should be a central pillar in our approach.
But we need a strategy to maximise gains. Health research and the life sciences can provide significant value – for our economy, society, and health. However, we will not maximise that value without a coherent strategy. The new 'R&D Roadmap' has begun that process for the research and development as a whole. However, we need to translate that into specific, bold strategies for strength R&D areas – like health and the life sciences.
This report outlines a progressive approach, based on three central pillars.
Snakes and ladders: Tackling precarity in social security and employment supportAcross the country, people are trying to make ends meet, build financial security and pursue their aspirations. But, in a vicious cycle of snakes and ladders, many are being pulled down into poverty.
Making markets: The City's role in industrial strategyTo tackle climate change, we need a significant increase in public and private capital investment.
Broken hearted: A spotlight paper on cardiovascular diseaseProgress on cardiovascular disease was a significant driver of better health and prosperity in the latter half of the 20th century, however progress has recently stalled – with indications it may be in reverse.